These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11328772)

  • 21. Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
    Lister PD; Sanders CC
    J Antimicrob Chemother; 1999 Jan; 43(1):79-86. PubMed ID: 10381104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses.
    Firsov AA; Lubenko IY; Vostrov SN; Kononenko OV; Zinner SH; Portnoy YA
    J Antimicrob Chemother; 2000 Nov; 46(5):725-32. PubMed ID: 11062191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.
    Zelenitsky SA; Ariano RE; Iacovides H; Sun S; Harding GK
    J Antimicrob Chemother; 2003 Apr; 51(4):905-11. PubMed ID: 12654762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin.
    Gerber J; Smirnov A; Wellmer A; Ragheb J; Prange J; Schütz E; Wettich K; Kalich S; Nau R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2169-72. PubMed ID: 11408247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.
    Zeitlinger MA; Dehghanyar P; Mayer BX; Schenk BS; Neckel U; Heinz G; Georgopoulos A; Müller M; Joukhadar C
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3548-53. PubMed ID: 14576116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).
    Noreddin AM; Marras TK; Sanders K; Chan CK; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2004 Nov; 24(5):479-84. PubMed ID: 15519481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.
    Child J; Mortiboy D; Andrews JM; Chow AT; Wise R
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2749-51. PubMed ID: 8593013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.
    Rodriguez-Cerrato V; McCoig CC; Michelow IC; Ghaffar F; Jafri HS; Hardy RD; Patel C; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3092-7. PubMed ID: 11600361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of newer quinolones in the empyema fluid.
    Liapakis IE; Kottakis I; Tzatzarakis MN; Tsatsakis AM; Pitiakoudis MS; Ypsilantis P; Light RW; Simopoulos CE; Bouros DE
    Eur Respir J; 2004 Sep; 24(3):466-70. PubMed ID: 15358708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.
    Granert C; Raud J; Waage A; Lindquist L
    Infect Immun; 1999 May; 67(5):2071-4. PubMed ID: 10225856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo.
    Sande MA; Korzeniowski OM; Allegro GM; Brennan RO; Zak O; Scheld WM
    Rev Infect Dis; 1981; 3(1):98-109. PubMed ID: 7221361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits.
    Krontz DP; Strausbaugh LJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):882-6. PubMed ID: 7235677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
    Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
    J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue pharmacokinetics of levofloxacin in human soft tissue infections.
    Bellmann R; Kuchling G; Dehghanyar P; Zeitlinger M; Minar E; Mayer BX; Müller M; Joukhadar C
    Br J Clin Pharmacol; 2004 May; 57(5):563-8. PubMed ID: 15089808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin.
    Firsov AA; Zinner SH; Vostrov SN; Portnoy YA; Lubenko IY
    J Antimicrob Chemother; 2002 Oct; 50(4):533-9. PubMed ID: 12356798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin.
    Pfister M; Zhang L; Hammarlund-Udenaes M; Sheiner LB; Gerber CM; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Jan; 47(1):138-43. PubMed ID: 12499181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis.
    Pioget JC; Wolff M; Singlas E; Laisne MJ; Clair B; Regnier B; Vachon F
    Antimicrob Agents Chemother; 1989 Jun; 33(6):933-6. PubMed ID: 2764544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in-vitro model simulating serum pharmacokinetic parameters.
    Shah PM; Schwärzel R
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():71-5. PubMed ID: 10404342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.